Exploring the role of cAMP in gabapentin- mediated pain attenuating effects in chronic constriction injury model in rats
DOI:
https://doi.org/10.1590/s2175-97902022e19362%20%20Keywords:
Neuropathic pain, Gabapentin, Milrinone, Chronic constriction injury, cAMPAbstract
It has been shown that an increase in cAMP leads to pain sensitization and gabapentin is shown to decrease cAMP levels. However, the impact of drugs modulating cAMP levels on analgesic actions of gabapentin is not studied. The present study investigates the effect of milrinone on pain attenuating effects of gabapentin in chronic constriction injury (CCI). Neuropathic pain was induced by putting four loose ligatures around the sciatic nerve. The pain assessment was done by noting the paw withdrawal threshold in the pinprick test, paw withdrawal latency in hot plate test and paw withdrawal duration in acetone drop test before surgery and on 14th- day post-surgery. There was a significant development of cold allodynia, mechanical and heat hyperalgesia on 14th day in CCI rats. Gabapentin (100 mg/kg) treatment for 14 days significantly attenuated pain, while milrinone (50 mg/kg) treatment for 14 days significantly exacerbated neuropathic pain in CCI-subjected rats. Milrinone (30 and 50 mg/kg) also attenuated analgesic actions of gabapentin in CCI-subjected rats, suggests that gabapentin may abolish neuropathic pain by increasing the intracellular levels of cAMP in CCI-subjected rats.
Downloads
References
Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth Analg.1998;87(6):1360-1366.
Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation. 1986;73(3 Pt 2):III10-24.
Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guideline on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153- 1169.
Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin. 1998;16(4):775-790.
Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002;59(5 Suppl):S14-59.
Baumans V, Van Loo PL. How to improve housing conditions of laboratory animals: the possibilities of environmental refinement. Vet J. 2013;195(1):24-32.
Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87-107.
Bie B, Peng Y, Zhang Y, Pan ZZ. cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci. 2005;25(15):3824-32.
Billie JK, Power I. The mechanism of action of gabapentin in neuropathic pain. Curr Opin Investig Drugs. 2006;7(1):33-39.
Burket LW, Greenberg MS, Glick M. Burkett’s Textbook of Oral Medicine. 10th ed. Philadelphia, PA: Lippincott Martin S Greenberg, Michael Glick (Eds), BC Decker Inc., Hamilton, 2003, 658.
Cai K, Nanga RP, Lamprou L, Schinstine C, Elliott M, Hariharan H, et al. The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology. 2012;37(13):2764-71.
Cao FL, Xu M, Wang Y, Gong KR, Zhang JT. Tanshinone IIA attenuates neuropathic pain via inhibition glial activation and immune response. Pharmacol Biochem Behav. 2015;128;1-7.
Carlsson KC, hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;8(3):328-336.
Chu S, Liu S, Duan W, Cheng Y, Jiang X, Zhu C, et al. The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi- target effect. Pharmacol Ther. 2016:S0163-7258;00003-00006.
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double- blind randomized placebo-controlled study. Clin Ter. 2000;151(3):145-148.
Dolan S, Nolan AM. Biphasic modulation of nocicep- tive processing by the cyclic AMP-protein kinase A signalingpathway in sheep spinal cord. Neurosci Lett. 2001;309(3):157-160.
Dooley DJ, Mieske CA, Borosky SK. Inhibition of K (+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neuroscience Lett. 2000;280(2):107-10.
Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain. Evidence-based recommendations Robert H. Pain . 2007;132(3):237-251.
Earl CQ, Linden J, Weglicki WB. Biochemical mechanism for the inotropic effect of the cardiotonic drug milrinone. J. Cardiovasc. Pharmacol. 1986;8(4):864-872.
Endoh M, Yamashita S, Taira N. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther. 1982;221(3):775-783.
Erichsen HK, Blackburn-Munro G. Pharmacological characterization of the spared nerve injury model of neuropathic pain. Pain . 2002;98(1-2):151e61.
Ferreira SH, Nakamura M. I. Prostaglandin hyperalgesia, a cAMP/Ca2+dependent process. Prostaglandins. 1979;18(2):179-190.
Field MJ, Oles OJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (Neurontin) and S-(+)-3-isobutyl GABA represent a novel class of selective antihyperalgesic agents. Br J Pharmacol. 1997;121(8):1513-22.
Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain . 2004;109(1-2):150-161.
Fukami k, Sekiguchi F, Kawabata A. Hydrogen sulfide and T-Type Ca 2+ channels in pain processing, neuronal differentiation and neuroendocrine secretion. Pharmacology. 2017;99(3-4):196-203.
Gagnon N, Almahrezi A, Schreier G. Methadone in the treatment of neuropathic pain. Pain Res Manag. 2003;8(3):149-154.
Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 1996;271(10):5768-76.
Goodman CW, Brett AS. Gabapentin and pregabalin for pain is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411-414.
Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol . 2008;153(2):319-334.
Gwak HV, Tan HY, Nam TS, Paik KS, Hulsebosch CE, Leem JW. Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J Neurotrouma. 2006;23(7):1111-1124.
Haga N, Kubota M, Miwa Z; Japanese Research Group on Congenital Insensitivity to Pain. Hereditary sensory and autonomic neuropathy types IV and V in Japan. Pediatr Int. 2015;57(1):30-6.
Hofer AM. Interactions between calcium and cAMP signaling. Curr Med Chem. 2012;19(34):5768-73.
Honerjager P, Schafer-Korting M, Reiter M. Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn- Schmiedebergs Arch Pharmacol. 1981:381(2);112-20.
Hucho T, Levine JD. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron. 2007;55(3):365-76.
Hilleman DE, Forbes WP. Roleofmilrinoneinthemanagement of congestive heart failure. DICP. 1989;23(5):357-362.
Jaggi AS, Singh N. Therapeutic target for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol Disord Drug Target. 2011;10(5):589-609.
Jaggi AS., Jain V, Singh N. Animal models of neuropathic pain. Fundam. Clin Pharmacol. 2011;25(1):1-28.
Jain V, Jaggi AS, Singh N. Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol Res. 2009;59(6):385- 392.
Jang JS, Kwon Y, Hwang SM, Kim JH, Yun T, Kim YS, et al. Comparison of the efficacy of a gabapentinoid with an opioid versus an opioid alone in patients with spinal cord stimulation. Pain Physician. 2018;21(4):E429-E434.
Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain . 2011;152(10):2204-2205.
Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation- driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533- 548.
Kemler MA, de Vet HC. Health-related quality of life in chronic refractory reflex sympathetic dystrophy (complex regional pain syndrome type I). J Pain Symptom Manage. 2000;20(1):68-76.
Khangura RK, Bali A, Kaur G, Singh N, Jaggi AS. Neuropathic pain attenuating effects of perampanel in an experimental model of chronic constriction injury in rats. Biomed Pharmacother. 2017;94:557-563.
Kim KH, Abdi S. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain . 2014;27(2):103-111.
Ko MH, Hsieh YL, Hsieh ST, Tseng TJ. Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy. Int J Mol Sci. 2015;16(3):4642-4665.
Konstaninou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimate. Spine. 2008;33(22):2464-2472.
Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013;36(3):237-51.
Kukkar A, Singh N, Jaggi AS. Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats. J Formos Med Assoc. 2014;113(12):921-8.
Kukkar A, Singh N, Jaggi AS. Neuropathic pain-attenuating potential of aliskiren in chronic constriction injury model in rats. J Renin Angiotensin Aldosterone Syst. 2013;14(2):116- 123.
Laird MA, Gidal BE. Use of gabapentin in the treatment of neuropathic pain. Ann Pharmacother. 2000;34(6):802 -807.
Landmesser U, Drexler H. Update on inotropic therapy in the management of acute heart failure. Curr Treat Options Cardiovasc Med. 2007;9(6):443-449.
Li CQ, Zhang JW, Dai RP, Wang J, Luo XG, Zhou XF. Surgical incision induces anxiety-like behavior and amygdala sensitization: effects of morphine and gabapentin. Pain Res Treat. 2010;2010:705874.
Li SS, Zhang WS, Ji D, Zhou YL, Li H, Yang JL, et al. Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI. Neurosci Lett . 2014;560:21-25.
Liou JT, Liu FC, Hsin ST, Yang CY, Lui PW. Inhibition of the cyclic adenosine monophosphate pathway attenuates neuropathic pain and reduces phosphorylation of cyclic adenosine monophosphate response element-binding in the spinal cord after partial sciatic nerve ligation in rats. Anesth Analg . 2007;105(6):1830-7.
Luo WJ, Yang F, Yang F, Sun W, Zheng W, Wang XL et al. Intervertebral foramen injection of ozone relieves mechanical allodynia and enhances analgesic effect of gabapentin in animal model of neuropathic pain. Pain Physician. 2017;20(5):E673-E685.
Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, et al. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci . 2001;21(6):1868-1875.
Martin DJ, McClelland D, Herd MB, Sutton KG, Hall MD, Lee K, et al. Gabapentin-mediated inhibition of voltage- activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology. 2002;42(3):353-66.
Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage.1995;10(4):265-266.
Meng B, Shen LL, Shi XT, Gong YS, Fan XF, Li J, et al. Effects of curcumin on TTX-R sodium currents of dorsal root ganglion neurons in type 2 diabetics rats with diabetic neuropathic pain. Neurosci Lett . 2015:605:59-64.
Navratilova E, Xie JV, Meske D, Qu C, Morimaura K, Okun A, et al. Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J Neurosci . 2015;35(18):7264-7271.
Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, et al. Gamma-aminobutyric acid B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol. 2001;59(1):144-152.
Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther . 1999;288(3):1026-30.
Ramsay, RE. Clinical efficacy and safety of gabapentin. Neurology . 1994;44(6 Suppl 5):S23-S30.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus- Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280(21):1837-1842.
Sarantopoulos C, McCallum B, Kwok WM, Hogan Q. Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons. Reg Anesth Pain Med. 2002;27(1):47-57.
Shao XM, Sun J, Jiang YL, Liu BY, Shen Z, Fang F, et al. Inhibition of the cAMP/PKA/CREB pathway contributes to the analgesic effects of electroacupuncture in the anterior cingulate cortex in a rat pain memory model. Neural Plast. 2016;2016:5320641.
Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain . 2000;85(3):405-14.
Sluka KA. Stimulation of deep somatic tissue with cap- saicin produces long-lasting mechanical allodynia and heat hypoalgesia that depends on early activation of the cAMP pathway. J Neurosci 2002;22(13):5687-5693.
Stanos SP, Galluzzi KE. Topical therapies in the management of chronic pain. Postgrad Med. 2013;125( Suppl 1):25-33.
Sumizono M, Sakakima H, Otsuka S, Terashi T, Nakanishi K, Ueda K et al. The effect of exercise frequency on neuropathic pain and pain-related cellular reactions in the spinal cord and midbrain in a rat sciatic nerve injury model. J Pain Res. 2018;11:281-291.
Surges R, Freiman TM, Feuerstein TJ. Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells. Epilepsia. 2003;44(2):150-6.
Tahmoush AJ, Schwartzman RJ, Hopp JL, Grothusen JR. Quantitative sensory studies in complex regional pain syndrome type 1/RSD. Clin J Pain . 2000;16(4):340-4.
Tamaddonfard E, Farshid AA, Maroufi S, Kazemi-Shojaei S, Erfanparast A, Asri-Rezaei S, et al. Effect of safranal, a constituent of saffron, and vitamin E on nerve functions and histopathology following crush injury of sciatic nerve in rats. Phytomedicine, 2014;21(5):717-723.
Vellani V, Giacomoni C. Gabapentin inhibits protein kinase c epsilon translocation in cultured sensory neurons with additive effects when coapplied with paracetamol (Acetaminophen). Sci World J. 2017;2017:3595903.
Venkatesan R, Ji E, Kim SY. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review. Biomed Res Int. 2015;2015:814068.
Wang Z, Wang J, Qin L, Zhang W. Tongluo Zhitong Prescription alleviates allodynia, hyperalgesia, and dyskinesia in the chronic constriction injury model of rats. Evid Based Complement Alternat Med. 2017;2017:8197281.
Yan K, Gao LN, Cui YL, Zhang Y, Zhou X. The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review). Mol Med Rep. 2016;13(5):3715-3723.
Yeh CY, Chung SC, Tseng FL, Tsai YC, Liu YC. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats. Acta Anaesthesiol Taiwan. 2011;49(4):144-148.
Zeng L, Alongkronrusmee D, van Rijn RM. An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res. 2017;10:219-228.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
